Bill

Bill > S4062


NJ S4062

Requires carriers to pass prescription drug savings to consumers.


summary

Introduced
08/23/2019
In Committee
08/23/2019
Crossed Over
Passed
Dead
01/08/2020

Introduced Session

2018-2019 Regular Session

Bill Summary

This bill requires carriers to pass prescription drug savings on to consumers. The bill provides that all compensation paid by a pharmaceutical manufacturer to a pharmaceutical benefits manager as a result of negotiations of a reduced price for a pharmaceutical between a pharmacy benefits manager and a manufacturer, in relation to a contract between a pharmacy benefits manager and a carrier related to its prescription drug benefits, shall be remitted to and retained by the carrier and must be used by the carrier to lower the premium for covered persons under the carrier's health benefits plan. In addition, the bill provides that a carrier shall annually file with the commissioner a report demonstrating how the carrier has complied with the provisions of the bill. Under the bill, "compensation" is defined as any direct or indirect financial benefit, including, but not limited to, rebates, discounts, credits, fees, grants, charge-backs, or other payments or benefits of any kind.

AI Summary

This bill requires carriers to pass prescription drug savings on to consumers. It stipulates that all compensation, such as rebates, discounts, or other payments, paid by a pharmaceutical manufacturer to a pharmacy benefits manager as a result of negotiations for reduced drug prices must be remitted to and retained by the carrier. The carrier is then required to use these savings to lower premiums for covered persons under its health benefits plan. Additionally, the bill mandates that carriers annually file a report with the commissioner demonstrating their compliance with these provisions.

Committee Categories

Business and Industry

Sponsors (2)

Last Action

Introduced in the Senate, Referred to Senate Commerce Committee (on 08/23/2019)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...